###### Strengths and limitations of this study

-   Population-level linked administrative data minimise the issues of selection and reporting bias, and loss to follow-up.

-   Consistency of results using population-level data from two patient populations provides a greater support for link between burn injury and some cancers.

-   Unable to examine the impact of burn severity on cancer risk due to lack of available data.

Introduction {#s1}
============

The burden of burn injury is a significant issue, not only in terms of the acute care perspective but also the chronic health effects resulting from the injury event and the subsequent treatments. While burns predominantly affect the skin, burns are associated with significant systemic effects,[@R1] depressed immune functioning[@R4] and prolonged periods of systemic catabolism and hypermetabolism.[@R9] Prompted by a clinical scenario of a diagnosis of hepatocellular carcinoma in a young male burn patient,[@R10] and the potential for malignancy after burn, an initial study of burn injury and total (all sites) cancer risk was undertaken.[@R11]

Results of our initial study demonstrated a gender effect with female burn survivors having an increased risk of all types of cancer.[@R11] In contrast to our results, a Swedish population-based study[@R12] that linked burn patient hospitalisation records and cancer registrations reported the risk of developing any form of cancer for combined gender was increased (standardised incidence ratio (SIR), 95% CI 1.11, 1.06 to 1.16), with the risk of lung cancer also significantly increased (SIR, 95% CI 1.39, 1.21 to 1.59). However, a Danish study of burn patients[@R13] found no significant increases in cancer (combined gender) for all malignant neoplasms, including all skin cancers (SIR, 95% CI 0.99, 0.93 to 1.06).

This previous study of burn injury and cancer risk used population-based data linked by the Western Australian Data Linkage System (WADLS).[@R14] Western Australia has a population of approximately 2.2 million, and as such, did not support detailed gender-specific and site-specific cancer incidence assessments with adequate statistical power. While the WADLS has linked datasets of Western Australians since the 1970s, other Australian states have only recently established record linkage systems and were not able to support this study. To extend the population base and enable further detailed examination of the observed gender effect and site-specific cancer incidence, approval was sought to access the Scottish population-based record linkage system, the Information Service Division (ISD) Scotland,[@R15] that has routinely linked health data since the 1980s.

This article reports a retrospective longitudinal study to explore cancer risk after burn injury using linked hospital morbidity, cancer and death data of persons hospitalised for burn injury in Western Australia and Scotland. The study aimed to, first, confirm the increased risk of total ('all sites') cancer observed in the preliminary Western Australian study of female burn survivors using the Scottish data; and, second, examine site-specific cancer risk among survivors of burn injury.

Methods {#s2}
=======

Study data were obtained from the WADLS[@R14] and the ISD (Scotland) of the National Health Service (NHS) National Services Scotland[@R15]. The WADLS and ISD Scotland are validated record linkage systems that routinely link administrative health data from core datasets for the entire population of Western Australia and Scotland, respectively.

An index burn injury was defined as the first hospital admission with a burn injury using primary and additional diagnosis International Classification of Diseases (ICD) codes 940--949 (ICD9) and T20-T31 (ICD10). A deidentified extraction of all linked hospital morbidity records (Hospital Morbidity Data System (HMDS), mortality (Death Register, Western Australia) and cancer records (Western Australia Cancer Registry (WACR)) for all persons admitted to hospital with an index burn injury in Western Australia, for the period 1 January 1983 to 31 December 2008, was performed by WADLS.[@R16] A corresponding deidentified extraction of all linked hospital morbidity records (Scottish Morbidity Records (SMR) 01), cancer registrations (SMR06) and death records (General Register Office for Scotland (GROS)) using the same burn cohort definition was undertaken by ISD Scotland. Hospital admissions data items included age at admission, gender, admission date, separation (or discharge) date, principal and additional diagnoses and external cause of injury.

The WACR was established in 1981 and is a population-based cancer registry based on mandatory notification of cancers from pathologists, haematologists and radiation oncologist, and cancer information from death records.[@R17] Malignant cancers are coded according to a modified Australian version of the International Classification of Diseases, Tenth Revision (ICD10-AM) and International Classification of Diseases for Oncology (ICD-O-3).

The Scotland Cancer Registry (SMR06) has recorded all incident cancers in Scotland from 1958, and since 1997 registration has been centralised at ISD Scotland.[@R18] The registry is responsible for the collection of information on all new cases of primary malignant neoplasms, carcinoma in situ (including grade III intraepithelial neoplasia), neoplasms of uncertain behaviour and (since 1 January 2000) benign brain and spinal cord tumours arising in residents of Scotland. Data quality is monitored using routine indicators, computer validation and ad hoc studies of data accuracy and completeness of ascertainment.[@R19] [@R20] The Scottish cancer notifications are coded using the ICD V.10 and the ICD-O.

Methods for analysis have been previously published.[@R11] An incident cancer was defined as a cancer diagnosis notification (C00-C96, excluding C44) after hospital admission for index burn injury. Analysis was restricted to malignant neoplasm notifications (C00-C96, excluding C44) for which total (all sites) and site-specific cancer incident rates were provided by WACR and ISD Scotland for respective populations. Records were excluded from the analysis if the date of cancer diagnosis was prior to date of discharge for index burn hospitalisation. When a record was identified as having more than one malignant neoplasm notification, each neoplasm was counted as an individual record; however, if multiple tumours of the skin (C43) with identical morphological characteristics (ie, the first three digits ICD-O-3 morphology code) were identified, they were recorded only once. Gender and age-specific cancer (total C00-C96, excluding C44) incident rates for the Western Australian and Scottish populations were pooled for the calendar periods 1983--1988, 1989--1993, 1994--1998, 1999--2003 and 2004--2008 to allow for changes in population cancer incidence during the study period.

For the determination of incident rates, the calculation of person-years began on the day of final hospital discharge for the index burn admission, and the study observation period continued until date of the defined cancer diagnosis, death or 31 December 2008, whichever occurred first. Individual calculations were conducted for total (all sites) and site-specific cancers. The observed number of cases of cancer and person-years at risk were calculated by age (5-year age groups), gender and calendar period (1983--1988, 1989--1993, 1994--1998, 1999--2003 and 2004--2008). The expected number of cancer cases was estimated by multiplying the specific number of person-years per category by the corresponding incidence of cancer in Western Australia, Scotland, and combined cancer incidence rates, provided by WACR and ISD Scotland. SIRs were calculated by dividing the observed number of cases by the number expected.[@R21] [@R22] The 95% CIs were defined under the assumption that the observed number of cancers followed the Poisson distribution.[@R23]

Separate SIR analyses for total (all sites) and site-specific cancers were conducted using country-specific data for respective burn patient cohorts (all burn depth) hospitalised from 1983 to 2008; total (all sites) SIRs were repeated for subcohorts of burn admissions from 1983 to 1987, with an optimum follow-up time. To further explore the gender impact of burn injury on cancer risk, total (all sites) cancer SIR analyses were repeated on age-restricted subcohorts classified to reflect the reproductive age at admission for burn injury: \<15; 15--49 and ≥50 years. All statistical analyses were performed using Stata statistical software V.11 (StataCorp LP, College Station, Texas, USA).

Results {#s3}
=======

As previously reported, in Western Australia from 1983 to 2008, there were 23 450 hospital index admissions for burn-related injury.[@R16] After exclusion of records with a history of cancer prior to separation date or death during hospital admission for burn, a total of 22 705 patient records were included in the analysis.[@R11] There were 673 patients with a first cancer notification after the date of separation for burn injury hospitalisation, and with inclusion of multiple malignancies, 759 cancer notifications were included in the SIR analyses as independent observations.

In Scotland from 1983 to 2008, there were a total of 37 890 persons hospitalised for an index burn-related injury. After exclusion of those with a history of cancer prior to separation date or death during hospital admission for burn, a total of 37 506 patients were included in the analysis. There were 2005 patients with a first cancer notification after the date of separation for burn injury hospitalisation, and with inclusion of multiple malignancies, 2260 cancer notifications were included in the SIR analyses as independent observations. The characteristics of the Western Australia and Scotland cohorts are presented in [table 1](#BMJOPEN2013003845TB1){ref-type="table"}.

###### 

Characteristics of burn injury patients included in analyses with no record of cancer prior to separation date of index burn admission, 1983--2008, by country

  ---------------------------------------------------------------------
  Characteristics                  Western Australia\   Scotland\
                                   N (%)                N (%)
  -------------------------------- -------------------- ---------------
  Total number burn admissions\*   22 705               3 537 506

  Gender: male                     15 481 (68.2)        23 896 (63.7)

  Age at index admission (years)                        

   \<15                            8135 (35.8)          14 579 (38.9)

   15--24                          4364 (19.2)          4495 (12.0)

   25--49                          7147 (31.5)          9554 (25.5)

   50--64                          1736 (7.7)           4080 (10.9)

   65+                             1323 (5.8)           4798 (12.8)

  Site of burn†                                         

   Head and neck                   6784 (15.4)          7592 (16.1)

   Trunk                           7553 (17.2)          8815 (21.0)

   Hand, wrist, upper limb         15 801 (35.9)        6984 (14.8)

   Hip, lower limb                 11 798 (26.8)        9531 (3.4)

   Eye                             379 (0.9)            1087 (2.3)

   Respiratory tract               212 (0.5)            163 (0.3)

   Other internal organs           124 (0.3)            165 (0.3)

   Multiple regions                656 (1.5)            3677 (7.8)

   Unspecified region              694 (1.6)            858 (1.8)

  Burn site depth†                                      

   Erythema                        8929 (20.9)          4815 (11.5)

   Partial thickness               18 449 (41.9)        6302 (15.0)

   Full thickness                  7095 (16.1)          4924 (11.7)

   Unspecified                     9528 (21.7)          25 869 (61.7)

  Calendar period of admission                          

   1983--1988                      5431 (23.9)          11 507 (30.7)

   1989--1993                      4200 (18.5)          7876 (21.0)

   1994--1998                      4755 (20.9)          7130 (19.0)

   1999--2003                      4265 (18.9)          5980 (15.9)

   2004--2008                      4054 (17.9)          5013 (13.4)

  Any comorbidity at index burn                         

  Yes                              2798 (12.3)          7679 (20.5)
  ---------------------------------------------------------------------

\*No previous record of cancer.

†Patients may have multiple burn sites per anatomical region per depth.

The Western Australia cohort (1983--2008; combined gender) was followed for a total of 283 306 person-years, with a mean follow-up time of 12.3 years (range \>0--25.9 years). The mean follow-up time for those with a cancer notification was 9.4 years (range \>0--25.4 years) and for those with no cancer notification was 12.4 years (range \>0--25.9 years). The Scotland cohort (1983--2008; combined gender) was followed for a total of 474 489 person-years, with a mean follow-up time of 12.6 years (range 0--26.0 years). The mean follow-up time for those with a cancer notification was 9.4 years (range \>0--25.8 years) and for those with no cancer notification was 12.7 years (range \>0--26 years).

For the Scottish cohort of burn-injury patients (combined gender), there was a marginal but significant difference (SIR, 95% CI 1.09, 1.05 to 1.10) in the overall risk of cancer for persons with a burn injury hospitalisation for the period 1983--2008, compared with the general population of Scotland. While a significant increase of 30% in cancer risk was estimated for females, there was no difference in cancer risk for males, when compared with the general population of Scotland (refer to [table 2](#BMJOPEN2013003845TB2){ref-type="table"}). For the subcohort of burn injury patients hospitalised during 1983--1988, the total observed number of cases of cancer (n=838) was statistically significantly lower than expected (n=953.4) with SIR (95% CI) of 0.88 (0.82 to 0.94), with males having a statistically significantly lower number of cases observed than expected. Refer to [table 2](#BMJOPEN2013003845TB2){ref-type="table"} for gender-specific SIRs for total (all sites) cancer for Scotland and Western Australian burn patients, hospitalised during 1983--1988 and 1983--2008.[@R11]

###### 

SIRs and 95% CIs and observed and expected number for total (all sites) cancer in persons hospitalised for burn injury in Western Australia and Scotland, during the periods 1983--2008 and 1983--1988

  ----------------------------------------------------------------------------------------------------------------------------------------------
                  Western Australia\*   Scotland                                                                             
  --------------- --------------------- ------------------- ------------------- ---------------------- --------------------- -------------------
  Total cohort\   0.97 (0.9 to 1.0)\    0.9 (0.8 to 1.0)\   1.1 (1.0 to 1.3)\   1.09 (1.05 to 1.10)\   0.96 (0.90 to 1.0)\   1.3 (1.2 to 1.4)\
  1983--2008      759: 785.5            515: 569.5          244: 216.0          2260: 2075.9           1249: 1303.2          1011: 772.6

  Subcohort\      1.0 (0.9 to 1.1)\     0.9 (0.8 to 1.0)\   1.4 (1.1 to 1.7)\   0.9 (0.8 to 0.9)\      0.8 (0.7 to 0.9)\     1.0 (0.9 to 1.2)\
  1983--1988      294 : 294.9           190 : 220.3         104: 74.6           838: 953.4             491: 614.3            347: 339.1
  ----------------------------------------------------------------------------------------------------------------------------------------------

\*Western Australian comparison data Duke *et al.*^11^

†SIR (95% CI) adjusted for age.

‡SIR (95% CI) adjusted for age and gender.

O:E, observed:expected; SIR (95% CI), standardised incidence ratio (95% CI).

Female genital cancers were grouped due to the small number of observed cancers in subgroups in the Western Australian data and unstable SIR results. Statistically significant increases in observed genital (combined) cancers for female burn patients in Western Australia and Scotland were found. The increased breast cancer incidence was statistically significant among female burn survivors in Scotland. Statistically significant increases in cancer incidence for combined gender for Western Australia and Scottish data were observed for cancers of the buccal cavity, liver and respiratory tract. Refer to [table 3](#BMJOPEN2013003845TB3){ref-type="table"} for gender-specific and site-specific cancer SIRs. For each of these cancers, female burn survivors in Western Australia and Scotland had a higher incidence than males when compared with respective general population data. For the majority of site-specific cancers selected, female burn survivors in Western Australia and Scotland had a higher number of observed cancers than expected, with SIRs of similar magnitude. However, SIR results for Scottish data reached statistical significance, reflecting the larger population base and respective higher number of cancer notifications.

###### 

SIRs and 95% CIs and observed and expected numbers for selected types of cancer in persons hospitalised for burns in Western Australia and Scotland, 1983--2008

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cancer Site ICD-10\*               Western Australia    Scotland                                                                           
  ---------------------------------- -------------------- ------------------- -------------------- -------------------- -------------------- --------------------
  Buccal cavity\                     1.4 (1.03 to 1.9)\   1.4 (1.0 to 1.9)\   1.5 (0.7 to 3.2)\    2.6 (2.2 to 3.1)\    2.4 (1.9 to 2.9)\    3.4 (2.5 to 4.8)\
  C00 to C14                         45: 32.6             38 : 28.1           7: 4.6               117: 45.0            83: 35.1             34 : 9.9

  Oesophagus\                        1.4 (0.9 to 2.4)\    1.5 (0.9 to 2.6)\   (0.3 to 4.5)\        1.6 (1.3 to 2.0)\    1.5 (1.1 to 1.9)\    1.9 (1.3 to 2.7)\
  C15                                15 : 10.50           13: 8.7             2: 1.8               82: 51.4             53 : 36.1            29 : 15.3

  Stomach\                           0.6 (0.3 to 1.1)\    0.5 (0.2 to 1.1)\   0.8 (0.3 to 2.6)\    1.2 (0.9 to 1.5)\    (0.8 to 1.5)\        (0.9 to 1.9)\
  C16                                10 : 17.0            7: 13.4             3: 3.6               73 : 63.2            5: 2.8               25 : 19.5

  Colorectal\                        0.7 (0.6 to 0.9)\    0.7 (0.5 to 0.9)\   0.9 (0.6 to 1.3)\    1.2 (1.1 to 1.4)\    (0.9 to 1.2)\        (1.3 to 1.8)\
  C18 to C20                         69: 96.3             45: 69.1            24: 27.2             268 : 221.8          142 : 140.5          125: 81.3

  Liver\                             2.6 (1.6 to 4.0)\    2.2 (1.3 to 3.7)\   4.7 (2.0 to 11.4)\   1.7 (1.2 to 2.5)\    (1.1 to 2.5)\        1.9 (1.0 to 3.7)\
  C22                                19: 7.4              14: 6.3             5: 1.1               31 : 18.0            22: 13.3             9: 4.7

  Pancreas\                          0.7 (0.4 to 1.3)\    0.9 (0.5 to 1.7)\   0.4 (0.1 to 1.6)\    1.1 (0.8 to 1.5)\    1.5 (1.03 to 2.0)\   0.6 (0.3 to 1.2)"\
  C25                                11: 15.3             9: 10.4             2: 5.0               44 : 39.6            34: 23.4             10: 16.2

  Larynx\                            5.7 (0.9 to 3.3)\    1.5 (0.7 to 3.0)\   6.0 (1.5 to 24.1)\   1.9 (1.4 to 2.5)\    1.5 (1.1 to 2.2)"\   4.2(2.3 to 7.7)\
  C32                                10: 5.7              8: 5.4              2: 0.3               39: 21.1             28: 18.5             11 : 2.6

  Respiratory tract\                 1.4 (1.1 to 1.6)\    1.3 (1.1 to 1.7)\   1.4 (0.9 to 2.2)\    1.5 (1.4 to 1.7)\    1.3 (1.2 to 1.5)\    1.9 (1.7 to 2.2)\
  C33 to C34                         101: 74.8            79 : 59.3           22 : 15.4            448 : 298.1          279 : 210.4          169 : 87.7

  Skin---malignant melanoma\         0.7 (0.6 to 0.9)\    0.7 (0.6 to 1.0)\   0.6 (0.4 to 1.0)\    0.8 (0.6 to 1.1)"\   0.7 (0.4 to 1.1)\    (0.4 to 1.1)\
  C43                                72: 102.0            57: 77.9            15: 24.1             38 : 48.5            19 : 28.4            19 : 20.0

  Breast"\                           (0.8 to 1.3)\        1.3 (0.2 to 9.2)\   1.0 (0.8 to 1.3)\    1.7 (1.5 to 1.9)\    0.7 (0.1 to 4.8)\    (1.5 to 1.9)\
  C50                                65: 62.4             1: 0.8              64 : 61.7            271 : 161.4          1 : 1.5              270: 160.0

  Female genital tract (combined)\                                            1.4 (1.0 to 2.0)\                                              1.7 (1.4 to 2.0)\
  C51 to C57                                                                  31 : 26.7                                                      114: 67.2

  Male genital tract (combined)\                          0.9 (0.8 to 1.1)\                                             1.1 (1.0 to 1.3)\    
  C60 to C63                                              141: 150.7                                                    210: 192.6           

  Prostate\                                               0.8 (0.6 to 0.9)\                                             1.1 (0.9 to 1.2)\    
  C61                                                     102: 135.9                                                    177: 165.5           

  Kidney, Bladder, UT C64 to C68     0.5 (0.3 to 0.7)"\   0.4 (0.2 to 0.7)\   0.7 (0.3 to 1.7)\    1.2 (1.0 to 1.4)\    1.2 (1.0 to 1.4)\    1.4 (1.0 to 1.9)\
                                     17: 37.9             12: 30.9            5: 7.0               135: 110.9           96: 82.8             39: 28.0

  Brain\                             1.2 (0.7 to 1.9)\    1.0 (0.5 to 1.8)\   1.7 (0.8 to 3.9)\    1.5 (1.1 to 2.0)\    1.4 (0.9 to 2.0)\    (1.0 to 2.9)\
  C71                                16: 13.9             10: 10.5            6: 3.5               39 : 27.0            26 : 19.2            13 : 7.8

  Lymphomas to all                   (0.7 to 1.4)\        0.8 (0.5 to 1.2)\   1.7 (1.03 to 2.7)\   1.1 (0.9 to 1.4)\    1.1 (0.8 to 1.4)\    1.2 (0.8 to 1.7)\
                                     36: 35.5             20: 26.0            16 : 9.6             75 : 68.0            48 : 45.0            27 : 23.0

  Myeloma/plasma                     1.3 (0.7 to 2.3)\    1.3 (0.7 to 2.6)\   1.2 (0.4 to 3.7)\    1.1 (0.7 to 1.6)\    (0.6 to 1.7)\        1.2 (0.6 to 2.2)\
                                     11: 8.6              8 : 6.1             3: 2.49              22 : 21.0            13 : 13.2            9: 7.8

  Leukaemia\'s to all                1.1 (0.8 to 1.7)\    1.1 (0.7 to 1.8)\   1.2 (0.6 to 2.5)\    1.3 (1.01 to 1.7)\   (0.73 to 1.4)\       (1.3 to 2.7)\
                                     26: 22.9             19: 17.0            7: 6.0               63 : 48.6            34 : 33.1            29: 15.5
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

\*ICD-10: International Classification of Diseases V.10.

†SIR (95% CI)adjusted for age and gender.

‡SIR (95% CI) adjusted for age (95% CI).

O:E, Observed:expected; SIR (95% CI), standardised incidence ratio (95% CI).

[Table 4](#BMJOPEN2013003845TB4){ref-type="table"} presents an SIR analyses of total (all sites) cancer risk repeated on age-restricted subcohorts, classified to reflect the reproductive age (\<15; 15--49 and ≥50 years) at admission for burn injury. For males in both WA and Scotland, no statistically significant differences were found across the three age groups. For female burn survivors in Scotland, the observed number of total cancer (all sites) exceeded that expected for each of the three age groups, with statistically significant results observed for the age groups 15--49 and for those aged 50 years and older. In the Western Australia data, excess cancers were observed for those younger than 15 years and for those 50 years and older, with statistical significance reached for the older age group; for females aged 15--49 years at burn injury, no difference in observed and expected total (all sites) cancer was found.

###### 

SIRs and 95% CIs and observed and expected number for total (all sites) cancer incidence, for persons hospitalised for burns in Western Australia and Scotland, by age group, 1983--1988

  ----------------------------------------------------------------------------------------------
  Age at first burn years   SIR (95% CI)\                                 
                            (observed: expected)                          
  ------------------------- ---------------------- ---------------------- ----------------------
  \<15                                                                    

   WA                       1.17 (0.82 to 1.68)\   1.19 (0.77 to 1.84)\   1.15 (0.62 to 2.14)\
                            (30 : 25)              (20 : 16)              (10 : 8.6)

   Scotland                 0.94 (0.69 to 1.28)\   0.72 (0.47 to 1.12)\   1.32 (0.86 to 2.02)\
                            (41 : 43.69)           (20 : 27.77)           (21 : 15.92)

  15--49                                                                  

   WA                       0.87 (0.77 to 0.99)\   0.87 (0.75 to 1.00)\   0.86 (0.69 to 1.1)\
                            (273 : 313)            (197 : 226)            (76 : 87)

   Scotland                 1.21 (1.12 to 1.31)\   1.04 (0.94 to 1.16)\   1.53 (1.36 to 1.73)\
                            (617 : 509.16)         (345 : 331.68)         (272 : 177.48)

  ≥50                                                                     

   WA                       1.02 (0.93 to 1.12)\   0.91 (0.82 to 1.02)\   1.32 (1.13 to 1.54)\
                            (456 : 446)            (298 : 326)            (158 : 120)

   Scotland                 1.05 (1.00 to 1.11)\   0.94 (0.88 to 1.00)\   1.23 (1.15 to 1.33)\
                            (1602 : 1523)          (884 : 943.75)         (718 : 579.25)
  ----------------------------------------------------------------------------------------------

\*SIR (95% CI) adjusted for age and gender.

†SIR (95% CI) adjusted for age.

SIR (95% CI), standardised incidence ratio (95% CI); WA, Western Australia.

Discussion {#s4}
==========

Methodological issues {#s4a}
---------------------

When population-level administrative data are used, data linkage minimises issues of selection and reporting bias, as well as loss to follow-up. Data quality of the Western Australia and Scottish Cancer Registers[@R17] [@R19] [@R20] and hospital morbidity datasets[@R24] [@R25] are assessed continually for accuracy and quality. Data of all index burn hospitalisations in Western Australia and Scotland from 1983 to 2008 were analysed with a follow-up time from discharge date, allowing for exclusion of prevalent cancers to support temporality of burn exposure and incident cancer. Cancer diagnoses from cancer registries in Western Australia and Scotland were independent of the record of burn injury in the respective hospital morbidity datasets. Minor burns treated in emergency departments were not included in the study. The burn patient cohorts under study are part of the respective reference populations, and as such, this may have a small diluting effect in the SIRs. Using parallel datasets from Western Australia and Scotland, with 2.2 million and 5.5 million populations, respectively, allowed examination of the consistency of results and trends across the populations.

The Western Australia hospital morbidity data records the principal diagnosis and up to 20 additional diagnosis fields, whereas the Scottish morbidity data include the principal diagnosis and five additional diagnosis fields. Consequent to the reduced number of additional diagnosis fields in the Scottish data, there was an absence of recorded supplementary total body surface area burned (TBSA%) data (ICD9 946; ICD10 T31) and a greater use of ICD codes for burns to multiple regions of the body (ICD9 946; ICD10 T29) rather than to individual anatomic burn sites, as reflected in [table 1](#BMJOPEN2013003845TB1){ref-type="table"}. This limited SIR analyses restricted to more severe burns of TBSA 20% or greater and incident rate ratio analysis to examine the effects of severity of burn injury (burn depth and TBSA%). Previous SIR analyses of total (all sites) cancer risk in Western Australia showed similar trends in results for all burn patients (severe and non-severe).[@R11]

Although this study had a follow-up period of up to 26 years from the date of separation for admission for burn injury, the follow-up period for many patients may not have provided sufficient observation time to enable identification of all potential malignancies, given the long latency period for many cancers. Further burn injury research is planned with comparison cohorts (non-burn trauma, no injury), using incidence rate ratio analyses to explore the patient (including lifestyle factors such as smoking and alcohol) and injury factors associated with the observed cancer risk.

Findings {#s4b}
--------

Analysis of the ISD Scotland data confirmed the results of our previous study: a statistically significant increase in total (all sites) cancer risk for female burn survivors with males experiencing no difference. The site-specific analyses clearly showed statistically significant increases in the number of observed cancers for combined gender in the Western Australia and Scottish data for the buccal cavity, larynx, liver, respiratory tract and oesophagus. There was also a general trend for increased cancer risk for a number of selected types of cancers for females and statistically significant increases in female genital cancers. Sub group analyses, defined crudely by reproductive age, did not elucidate any clear patterns of influence of oestrogen on cancer incidence, with female burn survivors in Scotland showing an increased risk across all age groups. For female burn survivors in WA, an increased risk for total (all sites) cancer was found for those younger than 15 (prepubescent) and 50 years and older (postmenopausal). The lack of gender difference for the subcohort of burn patients in Scotland hospitalised during 1983--1988 for total (all sites) cancer risk is difficult to explain. Possible reasons may include that females sustained less severe (\<20% TBSA) burns during this period; had less comorbidities and/or had better lifestyle factors than females hospitalised for burns during the remainder of the study period.

The site-specific analyses showed that while statistically significant increases in female genital cancers were found, there was also a general trend among female burn patients for excesses across a number of site-specific cancers examined, although these excesses did not always reach statistical significance, possibly due to small numbers. Statistically significant increases in the number of observed cancers for combined gender were found in the Western Australia and Scottish data for the buccal cavity, larynx, liver, respiratory tract and oesophagus. These results are similar to those found in a Danish study[@R13] and may be related to tobacco or alcohol use among this patient population. However, it would be expected that inhalation injury may also increase the cancer risk of the upper and lower respiratory tract, and in the case of the diagnosis of hepatocellular cancer in a young male (12 years of age) burn patient in Western Australia,[@R10] tobacco or alcohol use would be most unlikely attributable agents. Interestingly, the results of no increase in skin melanoma risk after burn injury in this study support findings of other population-based studies.[@R12] [@R13]

An alternative explanation for this increased incidence in cancer postburn may lie in the significant impact a burn injury has on the immune system, or the sustained oxidative and metabolic stress that are integral to the injury response. While burn injury predominantly affects the skin, it has been shown to cause a significant depression of humoral and cell-mediated immunity,[@R7] [@R26] [@R27] sustained elevated levels of oxidative stress[@R28] [@R29] and prolonged elevation of hypermetabolic and stress hormone levels.[@R30] [@R31] These effects have been demonstrated to persist for up to 3 years postinjury and can lead to long-term systemic impacts on other organs of the body.[@R1] [@R2] [@R32] Severe burn injury has been demonstrated to induce endoplasmic reticulum (ER) stress, in particular, in the liver.[@R37] ER stress is a stress-response that initially facilitates cell survival but can switch to a proapoptotic signal with prolonged stress.[@R37] [@R38] However, it has also been shown that the ER stress response can become maladaptive, facilitating adaptation to hypoxic environments and promoting tumour growth.[@R38] [@R39] It is plausible that the array of host responses combined with the impact of the injury, therefore, creates an environment of increased susceptibility to cancer.

In addition to the observed increase in some of the selected site-specific cancers, the data support evidence for a gender dimorphism (a systematic difference between individuals of different sex in the same species) in response to burn injury. After burn injury, gender has been shown to be an important factor with respect to poorer outcomes for mortality[@R40] and improved prognosis for multiple organ dysfunction syndrome,[@R44] and sepsis,[@R45] for females compared with males. Similar gender-based differences have also been reported in animal studies of burn injury.[@R46]

The impact of gender with respect to outcomes after burn injury is largely thought to stem from well-established differences in immune biology. There is a substantial volume of published literature to support a gender dimorphism in the immune response[@R51] and sepsis[@R45] following injury that have impacts on health and mortality.[@R41] [@R42] The majority of these studies support a more efficient and effective innate and adaptive immune responses in females, leading to a rapid clearance of infectious organisms driven by tissue resident cell populations.[@R55] This 'advantageous' response reduces the risk of infection in females compared with males[@R55] [@R56] but leads to elevated risk of autoimmune disease.[@R57] This dimorphism was thought to arise largely due to the impact of oestrogen on immune function.[@R58] [@R59] However, recent papers have demonstrated that these differences are not completely ablated by ovariectomy (in animal models)[@R55] and others have shown that oestrogen can be deleterious to the immune response.[@R60] This suggests a role of other mediators, most likely expressed on the X chromosome, in the maintenance of the differential immune response.[@R61] [@R62] The evidence for gender differences in the immune response, to thermal and other trauma, and its impact on outcomes is substantial. Here, the evidence of an increased cancer incidence in selected types of cancer after burn injury, with a greater effect in females, suggests the systemic immune response to burn injury may be a mediator of cancer susceptibility.

Conclusion {#s5}
==========

Using population-based linked data of all burn patients in Western Australia and Scotland, consistent trends were found in excesses in cancer notifications for a range of selected site-specific cancers with an elevated and more widespread increase in female burn patients. Overall, however, the increased cancer risk affected a small proportion of the respective burn patient cohorts. More research is required to understand the underlying mechanism(s) that may link burn injury to an increased risk of some cancers and why this is elevated in females, which may in turn enable identification of possible sites for intervention.
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